Cargando…

Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial

BACKGROUND: To quantify the variability among centers and to identify centers whose performance are potentially outside of normal variability in the primary outcome and to propose a guideline that they are outliers. METHODS: Novel statistical methodology using a Bayesian hierarchical model is used....

Descripción completa

Detalles Bibliográficos
Autores principales: Bayman, Emine O, Chaloner, Kathryn M, Hindman, Bradley J, Todd, Michael M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599203/
https://www.ncbi.nlm.nih.gov/pubmed/23324207
http://dx.doi.org/10.1186/1471-2288-13-5
_version_ 1782262909952327680
author Bayman, Emine O
Chaloner, Kathryn M
Hindman, Bradley J
Todd, Michael M
author_facet Bayman, Emine O
Chaloner, Kathryn M
Hindman, Bradley J
Todd, Michael M
author_sort Bayman, Emine O
collection PubMed
description BACKGROUND: To quantify the variability among centers and to identify centers whose performance are potentially outside of normal variability in the primary outcome and to propose a guideline that they are outliers. METHODS: Novel statistical methodology using a Bayesian hierarchical model is used. Bayesian methods for estimation and outlier detection are applied assuming an additive random center effect on the log odds of response: centers are similar but different (exchangeable). The Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) is used as an example. Analyses were adjusted for treatment, age, gender, aneurysm location, World Federation of Neurological Surgeons scale, Fisher score and baseline NIH stroke scale scores. Adjustments for differences in center characteristics were also examined. Graphical and numerical summaries of the between-center standard deviation (sd) and variability, as well as the identification of potential outliers are implemented. RESULTS: In the IHAST, the center-to-center variation in the log odds of favorable outcome at each center is consistent with a normal distribution with posterior sd of 0.538 (95% credible interval: 0.397 to 0.726) after adjusting for the effects of important covariates. Outcome differences among centers show no outlying centers. Four potential outlying centers were identified but did not meet the proposed guideline for declaring them as outlying. Center characteristics (number of subjects enrolled from the center, geographical location, learning over time, nitrous oxide, and temporary clipping use) did not predict outcome, but subject and disease characteristics did. CONCLUSIONS: Bayesian hierarchical methods allow for determination of whether outcomes from a specific center differ from others and whether specific clinical practices predict outcome, even when some centers/subgroups have relatively small sample sizes. In the IHAST no outlying centers were found. The estimated variability between centers was moderately large.
format Online
Article
Text
id pubmed-3599203
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35992032013-03-29 Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial Bayman, Emine O Chaloner, Kathryn M Hindman, Bradley J Todd, Michael M BMC Med Res Methodol Research Article BACKGROUND: To quantify the variability among centers and to identify centers whose performance are potentially outside of normal variability in the primary outcome and to propose a guideline that they are outliers. METHODS: Novel statistical methodology using a Bayesian hierarchical model is used. Bayesian methods for estimation and outlier detection are applied assuming an additive random center effect on the log odds of response: centers are similar but different (exchangeable). The Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) is used as an example. Analyses were adjusted for treatment, age, gender, aneurysm location, World Federation of Neurological Surgeons scale, Fisher score and baseline NIH stroke scale scores. Adjustments for differences in center characteristics were also examined. Graphical and numerical summaries of the between-center standard deviation (sd) and variability, as well as the identification of potential outliers are implemented. RESULTS: In the IHAST, the center-to-center variation in the log odds of favorable outcome at each center is consistent with a normal distribution with posterior sd of 0.538 (95% credible interval: 0.397 to 0.726) after adjusting for the effects of important covariates. Outcome differences among centers show no outlying centers. Four potential outlying centers were identified but did not meet the proposed guideline for declaring them as outlying. Center characteristics (number of subjects enrolled from the center, geographical location, learning over time, nitrous oxide, and temporary clipping use) did not predict outcome, but subject and disease characteristics did. CONCLUSIONS: Bayesian hierarchical methods allow for determination of whether outcomes from a specific center differ from others and whether specific clinical practices predict outcome, even when some centers/subgroups have relatively small sample sizes. In the IHAST no outlying centers were found. The estimated variability between centers was moderately large. BioMed Central 2013-01-16 /pmc/articles/PMC3599203/ /pubmed/23324207 http://dx.doi.org/10.1186/1471-2288-13-5 Text en Copyright ©2012 Bayman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bayman, Emine O
Chaloner, Kathryn M
Hindman, Bradley J
Todd, Michael M
Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial
title Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial
title_full Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial
title_fullStr Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial
title_full_unstemmed Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial
title_short Bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the IHAST trial
title_sort bayesian methods to determine performance differences and to quantify variability among centers in multi-center trials: the ihast trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599203/
https://www.ncbi.nlm.nih.gov/pubmed/23324207
http://dx.doi.org/10.1186/1471-2288-13-5
work_keys_str_mv AT baymanemineo bayesianmethodstodetermineperformancedifferencesandtoquantifyvariabilityamongcentersinmulticentertrialstheihasttrial
AT chalonerkathrynm bayesianmethodstodetermineperformancedifferencesandtoquantifyvariabilityamongcentersinmulticentertrialstheihasttrial
AT hindmanbradleyj bayesianmethodstodetermineperformancedifferencesandtoquantifyvariabilityamongcentersinmulticentertrialstheihasttrial
AT toddmichaelm bayesianmethodstodetermineperformancedifferencesandtoquantifyvariabilityamongcentersinmulticentertrialstheihasttrial